Skip to main content
Premium Trial:

Request an Annual Quote

Theradiag 2020 Revenues up 8 Percent

NEW YORK — Theradiag reported on Monday an 8 percent year-over-year increase in revenues for 2020 on strong sales of its theranostics products.

For the 12-month period ended Dec. 31, 2020, Theradiag's revenues rose to €10.4 million ($12.6 million) from €9.6 million the year before. Theranostics sales climbed almost 16 percent to €5.1 million from €4.4 million, with the company's Tracker line of therapeutic drug monitoring tests selling particularly well in the US, where the products are commercialized in collaboration with HalioDx.

In vitro diagnostics revenues, meanwhile, edged up 2 percent to €5.3 million from €5.2 million with €900,000 in sales of Theradiag's SARS-CoV-2 antigen tests and related products helping to offset the impact of nonrecurring instrumentation sales recorded in 2019.

At the end of 2020, Croissy Beaubourg, France-based Theradiag had cash totaling €3.5 million.

The Scan

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.

Family Genetic Risk Score Linked to Diagnostic Trajectory in Psychiatric Disorders

Researchers in JAMA Psychiatry find ties between high or low family genetic risk scores and diagnostic stability or change in four major psychiatric disorders over time.

Study Questions Existence of Fetal Microbiome

A study appearing in Nature this week suggests that the reported fetal microbiome might be the result of sample contamination.

Fruit Fly Study Explores Gut Microbiome Effects on Circadian Rhythm

With gut microbiome and gene expression experiments, researchers in PNAS see signs that the microbiome contributes to circadian rhythm synchronicity and stability in fruit flies.